Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Kimberly-Clark to buy maker of Tylenol

Digest more
 · 1d · on MSN
Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal
Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

Continue reading

 · 17h · on MSN
Could Huggies and Tylenol be a good fit? Kimberly-Clark is buying Kenvue for $48 billion
 · 1d · on MSN
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy
1don MSN

Kimberly-Clark Tanks on Deal to Buy Tylenol Maker Kenvue

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, ...
1don MSN

Tylenol trust crisis: Trump, RFK Jr. and Texas lawsuits slam Kenvue

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Wins NYC mayor’s race
Wins VA governor's race
UPS plane crashes in KY
US warns of 'mass chaos'
Ex-US VP Cheney dies
Six Flags America closes
At least 26 killed in PH
Light of 10 trillion suns
First Brands sues founder
Rejects Disney’s request
Paul-Davis bout called off
Maldives bans smoking
China blames Netherlands
To be taken private
Loses most of UK lawsuit
Two MA men arrested
Cardinal Dominik Duka dies
Starts redistricting process
Todd Snider cancels tour
To cut corporate jobs
Trump on SNAP payments
Transitions to new leadership
United flight evacuated
To build AI factory
To cut thousands of jobs
Renominated by Trump
Parent company explores sale
Feedback
  • Privacy
  • Terms